Rising prevalence of various chronic diseases resulting in need for facilities to provide enhanced and faster diagnostics is a key factor driving market revenue growth.
Market Size - USD 2.18 Billion in 2020, Market Growth - CAGR of 9.1%, Market Trends - Constant focus on research and development for technological progressions and product launches by major players.
The global live cell imaging market size is expected to reach USD 4.35 Billion in 2028, and register a CAGR of 9.1% during the forecast period. Increasing adoption of live cell imaging by various major pharmaceutical companies in research, development, and launch of new as well as personalized medicines is a major factor expected to drive growth of the global live cell imaging market to a significant extent.
Live cell imaging allows researchers to observe and analyze cell structures in real time. These observations related to dynamic changes offers in-depth insights into operations of a cell better than snapshots provided by fixed-cell imaging.
However, high cost of content screening systems, and dearth of skilled professionals are major factors that could hamper growth of the global live cell imaging market.
Some Key Findings From the Report:
For the purpose of this report, the global live cell imaging market is segmented on the basis of product type, technology, application, end use, and region:
Product Type Outlook (Revenue, USD Billion; 2018 - 2028)
Technology Outlook (Revenue, USD Billion; 2018 - 2028)
Application Outlook (Revenue, USD Billion; 2018 - 2028)
End Use Outlook (Revenue, USD Billion; 2018 - 2028)
Region Outlook (Revenue, USD Billion; 2018 - 2028)
Reasons to Buy the Report
Market Size - USD 2.18 Billion in 2020, Market Growth - CAGR of 9.1%, Market Trends - Constant focus on research and development for technological progressions and product launches by major players.
The global live cell imaging market size is expected to reach USD 4.35 Billion in 2028, and register a CAGR of 9.1% during the forecast period. Increasing adoption of live cell imaging by various major pharmaceutical companies in research, development, and launch of new as well as personalized medicines is a major factor expected to drive growth of the global live cell imaging market to a significant extent.
Live cell imaging allows researchers to observe and analyze cell structures in real time. These observations related to dynamic changes offers in-depth insights into operations of a cell better than snapshots provided by fixed-cell imaging.
However, high cost of content screening systems, and dearth of skilled professionals are major factors that could hamper growth of the global live cell imaging market.
Some Key Findings From the Report:
- Among the product type segments, the instruments segment accounted for the largest revenue share of 39.5% in 2020, followed by the consumables segment in terms of revenue share.
- Among the application segments, the cell biology segment accounted for major revenue share in 2020, and is expected to continue to contribute largest revenue share over the forecast period, due to growing number of researches on molecular interaction networks by major players.
- In 2020, the Asia Pacific market size was USD 603.5 Million, owing to rising prevalence of various types of cancer, cardiovascular diseases, and diabetes, coupled with increasing initiatives taken by governments in countries in the region for research and development of treatment for these chronic diseases.
- Key players profiled in the report include Carl Zeiss, Meditec AG, Leica Microsystems, Nikon Corporation, Becton, Dickinson and Company, GE Healthcare, Olympus Corporation, Thermo Fisher Scientific, Sigma-Aldrich Corporation, PerkinElmer and Molecular Devices. The market players have adopted various strategies including mergers, acquisitions, partnerships, and new product developments, among other strategies, to stay ahead of the competition and expand market footprint.
For the purpose of this report, the global live cell imaging market is segmented on the basis of product type, technology, application, end use, and region:
Product Type Outlook (Revenue, USD Billion; 2018 - 2028)
- Instruments
- Microscopes
- Cell Analyzers
- Image Capturing
- Consumables
- Software
- Others
Technology Outlook (Revenue, USD Billion; 2018 - 2028)
- Fluorescence Resonance Energy Transfer (FRET)
- Time Lapse Microscopy
- Fluorescence Recovery After Photo-bleaching (FRAP)
- High Content Screening (HCS)
- Others
Application Outlook (Revenue, USD Billion; 2018 - 2028)
- Cell Biology
- Stem Cells
- Developmental Biology
- Drug Discovery
- Others
End Use Outlook (Revenue, USD Billion; 2018 - 2028)
- Pharmaceutical and Biotechnology Companies
- Research Institutes
- Hospitals
- Diagnostic Laboratories
- Others
Region Outlook (Revenue, USD Billion; 2018 - 2028)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Benelux
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia Pacific
- Latin America
- Brazil
- Rest of Latin America
- Middle East and Africa
- Saudi Arabia
- UAE
- South Africa
- Rest of Middle East & Africa
Reasons to Buy the Report
- A robust analysis and estimation of the Live Cell Imaging Market with four levels of quality check - in-house database, expert interviews, governmental regulation, and a forecast specifically done through time series analysis
- A holistic competitive landscape of the all the major players in the Live Cell Imaging Market. The report covers their market shares, strategic initiatives, new product launches, R&D expenditure, M&As, Joint ventures, expansionary plans, product wise metric space analysis and key developments
- Go-to-market strategies specifically formulated in line with location analysis which takes into the factors such as government regulations, supplier mapping, supply chain obstacles, and feedback from local vendors
- Most deep dive segmental bifurcation available currently in the market. Our stellar methodology helps us understand the overall gamut of the supply chain and will help you explain the current market dynamics
- Special focus given on vendor landscape, supplier portfolio, customer mapping, production capacity, and yearly capacity utilization
Table of Contents
Chapter 1. Market Synopsis
Chapter 2. Executive Summary
Chapter 3. Indicative Metrics
Chapter 4. Global Live Cell Imaging Segmentation & Impact Analysis
Chapter 5. Global Live Cell Imaging Market by Product Type Insights & Trends
Chapter 6. Global Live Cell Imaging Market by Application Type Insights & Trends
Chapter 7. Global Live Cell Imaging Market By Technology Type Insights & Trends
Chapter 8. Global Live Cell Imaging Market By End Use Insights & Trends
Chapter 9. Global Live Cell Imaging Market Regional Outlook
Chapter 10. Competitive Landscape
Companies Mentioned
- Carl Zeiss
- Meditec AG
- Leica Microsystems
- Nikon Corporation
- Becton Dickinson and Company
- GE Healthcare
- Olympus Corporation
- Thermo Fisher Scientific
- Sigma-Aldrich Corporation
- PerkinElmer
- Molecular Devices